We also found that the expression level of DARS1-AS1 was higher in the mesenchymal subtype tumors than in the classical and proneural subtype tumors in GBM (25), and its higher expression was significantly associated with shorter overall survival of GBM patients (log-rank test, P = 0.0023; fig. Here, DARS1 is linked to glioblastoma.